Moderna

Investor Outlook: Moderna posts stronger Q3 as cost-cutting cushions weaker Covid vaccine sales BNN Bloomberg11:50Moderna Vaccine Coronavirus Vaccine Pharma
In the last 7 days
Moderna Approves Stock Option Exchange Program TipRanks17:03 13-Nov-25
We wanted to help end the pandemic. But no one considered the consequences... we're scarred for … MailOnline17:56 11-Nov-25
Telemark Asset Management Builds Position in Beaten-Down Biotech Stock. The Motley Fool13:05 10-Nov-25
What Are Wall Street Analysts’ Target Price for Moderna Stock? Barchart09:32 10-Nov-25
Edi Hila: Moderna Museet Malmo presents the first Scandinavian retrospective of Albania's… ArtDaily19:39 9-Nov-25
In the last month
Kin Museum revisits a landmark 1965 exhibition ArtDaily20:33 8-Nov-25
Moderna (MRNA) Reports Q3 Earnings: What Key Metrics Have to Say Zacks23:34 6-Nov-25
Moderna Reports Q3 2025 Financial Results TipRanks23:33 6-Nov-25
Moderna’s Earnings Call: Balancing Achievements and Challenges TipRanks19:28 6-Nov-25
Moderna's losses narrow, Coach-maker's outlook disappoints Yahoo! UK & Ireland14:20 6-Nov-25
Moderna Q3 Earnings Beat, Stock Up on Revised '25 Spending Plans Zacks13:02 6-Nov-25
mRNA Vaccine Maker Moderna Lowers R&D Spending, Tightens Sales Forecast Benzinga12:39 6-Nov-25
Moderna Q3 2025 Earnings Call Transcript Benzinga12:37 6-Nov-25
Moderna leans on cost cuts, pipeline as vaccine sales dip BioPharma Dive12:17 6-Nov-25
Investor Outlook: Moderna posts stronger Q3 as cost-cutting cushions weaker Covid vaccine sales BNN Bloomberg11:50 6-Nov-25
Moderna (MRNA) Reports Q3 Loss, Tops Revenue Estimates Zacks09:18 6-Nov-25
Moderna Posts Loss In Q3 RTT News08:46 6-Nov-25
Moderna (NASDAQ:MRNA) Posts Better-Than-Expected Sales In Q3, Stock Soars Barchart08:43 6-Nov-25
Moderna Gains on Sharp Cost Cuts as Covid Vaccine Declines Yahoo! UK & Ireland07:53 6-Nov-25
Should You Buy Moderna Stock Ahead of Q3 Earnings Report? Zacks09:42 4-Nov-25
Inside Biotech: Moderna opens new front in oncology with T-cell engager therapy Proactive Investors (Australia)20:03 3-Nov-25
Moderna Stock Is Sliding Monday: What's Going On? Benzinga16:14 3-Nov-25
Why Moderna (MRNA) Stock Is Falling Today Barchart13:48 3-Nov-25
Why Moderna (MRNA) Stock Is Trading Lower Today Barchart16:44 31-Oct-25
Moderna (mRNA) Stock Is Trading Lower Friday: What's Going On? Benzinga16:09 31-Oct-25
Moderna, Inc. (MRNA) is Attracting Investor Attention: Here is What You Should Know Zacks10:07 31-Oct-25
Up 14% yesterday, is it the end for this train wreck in my Stocks and Shares ISA? Motley Fool (UK)06:46 31-Oct-25
Strength Seen in Moderna (MRNA): Can Its 13.9% Jump Turn into More Strength? Zacks06:02 31-Oct-25
S&P 500 Gains and Losses Today: Meta Stock Drops After Earnings; Moderna Surges Yahoo! US16:47 30-Oct-25
Moderna Stock (MRNA) Surges 17% on Buyout Speculation ahead of Q3 Earnings TipRanks15:26 30-Oct-25
New study offers insights into how the immune system changes with age STAT08:45 30-Oct-25
STAT Plus: How Moderna, the company that helped save the world, unraveled STAT04:37 30-Oct-25
A Look at Moderna (MRNA) Valuation After mRNA-1647 Fails Key Phase III Trial Simply Wall St12:32 29-Oct-25
Moderna named a top employer by Science for eleventh consecutive year Manufacturing Chemist04:14 28-Oct-25
Vertex and Moderna’s VX-522 Study: A Potential Breakthrough in Cystic Fibrosis Treatment TipRanks18:39 27-Oct-25
Moderna Says Vax Efficacy Math Doesn't Show Investor Fraud Law36015:48 27-Oct-25
Eurest wins new catering contract with Moderna at Harwell Campus Public Sector Catering04:21 27-Oct-25
Eurest wins new contract with Moderna at Harwell Campus Public Sector Catering03:51 27-Oct-25
Moderna (MRNA) Outperforms Broader Market: What You Need to Know Zacks18:50 24-Oct-25
Moderna’s cytomegalovirus vaccine fails a phase III BioWorld17:17 23-Oct-25
Moderna Flunks Pivotal CMV Trial, But Read-Through Unlikely Scrip Pharma Intelligence16:44 23-Oct-25
Moderna Stops Cmv Program As Vaccine Falls Short In Preventing Infection Benzinga10:41 23-Oct-25
Tesla, Zions Bancorp, Moderna: Top Analyst Calls Yahoo! UK & Ireland10:27 23-Oct-25
STAT Plus: Pharmalittle: We’re reading about a Moderna setback, CVS playing hardball with… STAT10:13 23-Oct-25
STAT Plus: Moderna faces CMV woes — but sees hope in cancer pipeline STAT09:40 23-Oct-25
Moderna scraps mRNA vaccine in congenital CMV on Phase III failure Clinical Trials Arena09:23 23-Oct-25
Eurest takes Moderna catering deal at Harwell Campus Facilitate Magazine07:35 23-Oct-25
Moderna drops mRNA jab for CMV after phase 3 fail pharmaphorum07:05 23-Oct-25
Moderna Earnings Preview: What to Expect Barchart05:26 23-Oct-25
Moderna halts development of birth defect vaccine after trial setback Reuters05:00 23-Oct-25
STAT Plus: Despite a tough year, Moderna forges ahead with cancer therapies STAT04:39 23-Oct-25
Moderna says CMV vaccine once seen as future blockbuster fails key study BioPharma Dive21:11 22-Oct-25
Moderna says key study of its Cmv vaccine, expected to be its next big win, failed Boston Globe17:01 22-Oct-25
Moderna slides after halting development of birth defect vaccine Yahoo! US16:56 22-Oct-25
Moderna Vaccine Fails to Stop Virus Tied to Birth Defects (1) Bloomberg Law16:19 22-Oct-25
STAT Plus: Moderna says key study of its CMV vaccine, expected to be its next big win, failed STAT16:16 22-Oct-25
Prediction: Moderna Will Soar Over the Next 5 Years. Here's 1 Reason Why. The Motley Fool13:44 22-Oct-25
Moderna-backed ALA campaign takes a shot at boosting respiratory vaccine uptake FiercePharma13:11 22-Oct-25
Covid-19 vaccines may help some cancer patients fight tumors The Economic Times11:51 22-Oct-25
Should You Buy Moderna Right Now? The Motley Fool10:10 22-Oct-25
Moderna Stock Is at a Crossroads. Is the Path Ahead One of Profit or Pain for MRNA? Barchart15:36 21-Oct-25
mRNA Therapeutics and Global Markets to 2030, Profiles of Leading Companies - Moderna, Pfizer,… Business Wire (Press Release)12:15 21-Oct-25
Moderna cofounder issues warning: Assault on science ‘isn’t going to stop at mRNA’ Boston Globe16:10 20-Oct-25
STAT Plus: Pharmalittle: We’re reading about ESMO cancer trial results, warnings from Moderna… STAT09:38 20-Oct-25
STAT Plus: Moderna co-founder Noubar Afeyan issues warning: Assault on science ‘isn’t going to… STAT04:32 20-Oct-25
How Moderna's (MRNA) mRNA-4359 Cancer Vaccine Data Is Shaping Its Pipeline Diversification Narrative Simply Wall St02:27 19-Oct-25
The UK is positioning itself as a hub for mRNA science and innovation New Statesman04:51 17-Oct-25
Infographic: Moderna’s strategic partnership with the UK government New Statesman04:40 17-Oct-25
An investment in the future New Statesman04:30 17-Oct-25
A flagship for vaccine innovation New Statesman04:30 17-Oct-25

      
            
      
    view more headlines
   
      
      
      
13 Nov 17:03
   
About our Moderna news

Latest news on Moderna, a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.
Moderna

Latest News

About our Moderna news

Business Top Stories
